« Previous
Next »
Journal of Clinical Lipidology
Volume 2, Issue 6
, Pages
418-425
, December 2008
Rosuvastatin reduces non–high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
To access this article, please choose from the options below
PII: S1933-2874(08)00888-X
doi: 10.1016/j.jacl.2008.10.002
© 2008 National Lipid Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Clinical Lipidology
Volume 2, Issue 6
, Pages
418-425
, December 2008
